Sort by
Refine Your Search
-
PeopleSoft Seniority Unit Terms of Appointment Staff - 12 month Position Pension Eligibility ABP Qualifications Minimum Education and Experience PhD, MD or MD/PhD in clinical or counseling psychology
-
, masters, post-master and doctoral degree programs that are preparing nurse leaders of today and tomorrow. New Jersey’s academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes
-
- Regular Salaried Payroll Designation PeopleSoft Seniority Unit Terms of Appointment Staff - 12 month Position Pension Eligibility ABP Qualifications Minimum Education and Experience A PhD and/or MD degree
-
/2026 Qualifications Minimum Education and Experience A doctoral degree in epidemiology, social and behavioral health sciences, biostatistics, or a related field. A record of peer-reviewed publications
-
and Experience PhD, MD, or equivalent doctoral degree in Neuroscience, Biomedical Engineering, Computer Science, or a related field. Candidates in ABD (all but degree) status will also be considered
-
Posting Open Date 06/08/2026 Posting Close Date 08/04/2026 Qualifications Minimum Education and Experience PhD or MD in Neuroscience, Psychology, Cognitive Science, Public Health, or related discipline
-
Posting Open Date 06/08/2026 Posting Close Date 08/14/2026 Qualifications Minimum Education and Experience PhD or MD in Neuroscience, Psychology, Cognitive Science, Public Health, or related discipline
-
interested in how viral and microbial factors modulate host receptors, immune responses, and metabolic pathways. The Post‑Doctoral Associate will lead independent projects, perform in vivo and in vitro
-
faculty serve in numerous leadership roles. Position Status Full Time Posting Number 26FA0645 Posting Open Date Posting Close Date 11/30/2026 Qualifications Minimum Education and Experience A doctorate
-
of the Principal Investigator the Post doctoral Associate will perform research. The Altindis Lab studies viral insulin/IGF‑1‑like peptides (VILPs) – sequences encoded by viruses that mimic human insulin and IGF‑1